Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Herpesvirus is found in Kaposi's sarcoma lesions in most patients; it is therefore
possible that the herpesvirus has a role in causing Kaposi's sarcoma. Cidofovir is an
antiviral drug that acts against many types of herpesvirus, and may be an effective treatment
for Kaposi's sarcoma.
PURPOSE: Phase II trial to study the effectiveness of cidofovir in treating patients with
Kaposi's sarcoma with or without HIV infection.